ezetimibe
UkraineDrugs containing this active substance
-
The drug is intended for the treatment of primary hypercholesterolemia (elevated cholesterol levels) in adults as an adjunct to diet. It is also used to reduce the risk of cardiovascular disease in patients with a history of ischemic heart disease or acute coronary syndrome.
Form: tablets, film-coated
Active substance Dosage rosuvastatin 10 mg ezetimibe 10 mg ATC: C10BA06
-
The drug is intended for adults as an adjunct to diet therapy in primary hypercholesterolemia (elevated cholesterol levels), as well as to reduce the risk of cardiovascular disease in patients with a history of ischemic heart disease or acute coronary syndrome.
Form: tablets, film-coated
Active substance Dosage rosuvastatin 20 mg ezetimibe 10 mg ATC: C10BA06
-
The drug is intended for adults as an adjunct to diet in the treatment of primary hypercholesterolemia (elevated cholesterol levels). It is also used to reduce the risk of cardiovascular disease in patients with a history of ischemic heart disease or acute coronary syndrome.
Form: tablets, film-coated
Active substance Dosage rosuvastatin 40 mg ezetimibe 10 mg ATC: C10BA06
-
The drug is prescribed for adults to lower cholesterol levels (specifically LDL — 'bad' cholesterol) and triglycerides in cases of hypercholesterolemia or mixed dyslipidemia. It is also used for the prevention of cardiovascular diseases in patients with a history of ischemic heart disease or acute coronary syndrome.
Form: tablets, film-coated
Active substance Dosage rosuvastatin 10 mg ezetimibe 10 mg ATC: C10BA06
Manufacturer: Medicair Biosciences Laboratories S.A.
-
The drug is prescribed for adults to lower cholesterol levels (specifically LDL — 'bad' cholesterol) and triglycerides in cases of hypercholesterolemia or mixed dyslipidemia. It is also used to prevent cardiovascular diseases in patients with a history of ischemic heart disease or acute coronary syndrome.
Form: tablets, film-coated
Active substance Dosage rosuvastatin 20 mg ezetimibe 10 mg ATC: C10BA06
Manufacturer: Medicair Biosciences Laboratories S.A.
-
The drug is used to lower cholesterol levels in primary hypercholesterolemia (as an adjunct to diet if statins are insufficient or unsuitable), as well as to prevent cardiovascular complications in patients with a history of ischemic heart disease or acute coronary syndrome. It is also indicated for homozygous familial hypercholesterolemia and sitosterolemia.
Form: tablets
Active substance Dosage ezetimibe 10 mg ATC: C10AX09
Manufacturer: Hetero Labs Limited
-
The drug is indicated for adults with elevated cholesterol levels (hypercholesterolemia) or mixed dyslipidemia. It is used as adjunctive therapy to lower LDL cholesterol levels, particularly in patients who cannot achieve target levels with statins or who have an intolerance to them.
Form: tablets, film-coated
Active substance Dosage bempedoic acid 180 mg ezetimibe 10 mg ATC: C10BA10
Manufacturer: Synthon Hispania, S.L. (manufacturing, primary and secondary packaging, quality control, batch release)
-
The drug is prescribed to lower cholesterol levels in primary hypercholesterolemia (as an adjunct to diet if statins are insufficient or cannot be used). It is also used to prevent cardiovascular events in patients with a history of ischemic heart disease or acute coronary syndrome, as well as in certain rare genetic metabolic disorders.
Form: tablets
Active substance Dosage ezetimibe 10 mg ATC: C10AX09
Manufacturer: PJSC Pharmaceutical Plant EGIS
-
The drug is used to lower cholesterol and triglyceride levels in adults. It is prescribed for the prevention of cardiovascular complications in patients with a history of ischemic heart disease or acute coronary syndrome, as well as for adjunctive therapy in hypercholesterolemia.
Form: tablets, film-coated
Active substance Dosage rosuvastatin 40 mg ezetimibe 10 mg ATC: C10BA06
Manufacturer: Elpen Pharmaceutical Co. Inc.
-
The drug is used to reduce the risk of cardiovascular complications in patients with a history of ischemic heart disease or acute coronary syndrome. It is also prescribed as an adjunct to diet for the treatment of adults with hypercholesterolemia.
Form: tablets, film-coated
Active substance Dosage rosuvastatin 5 mg ezetimibe 10 mg ATC: C10BA06
-
The drug is intended to reduce the risk of cardiovascular complications in patients with a history of ischemic heart disease or acute coronary syndrome. It is also used as an adjunct to diet in the treatment of adults with high cholesterol (hypercholesterolemia).
Form: tablets, film-coated
Active substance Dosage rosuvastatin 10 mg ezetimibe 10 mg ATC: C10BA06
-
The drug is intended to reduce the risk of cardiovascular complications in patients with a history of ischemic heart disease or acute coronary syndrome. It is also used as an adjunct to diet in the treatment of adults with high cholesterol (hypercholesterolemia).
Form: tablets, film-coated
Active substance Dosage rosuvastatin 15 mg ezetimibe 10 mg ATC: C10BA06
-
The drug is indicated to reduce the risk of cardiovascular complications in patients with a history of ischemic heart disease or acute coronary syndrome. It is also used as an adjunct to diet in the treatment of adults with elevated cholesterol levels (hypercholesterolemia).
Form: tablets, film-coated
Active substance Dosage rosuvastatin 20 mg ezetimibe 10 mg ATC: C10BA06
-
The drug is indicated to reduce the risk of cardiovascular complications in patients with a history of ischemic heart disease or acute coronary syndrome. It is also used as an adjunct to diet in the treatment of adults with hypercholesterolemia.
Form: tablets, film-coated
Active substance Dosage rosuvastatin 40 mg ezetimibe 10 mg ATC: C10BA06
-
The drug is used to lower cholesterol and triglyceride levels in adults. It is prescribed for the prevention of cardiovascular complications in patients with a history of ischemic heart disease or acute coronary syndrome, as well as for adjunctive therapy in hypercholesterolemia.
Form: tablets, film-coated
Active substance Dosage rosuvastatin 20 mg ezetimibe 10 mg ATC: C10BA06
Manufacturer: Elpen Pharmaceutical Co. Inc.
-
The drug is used to lower cholesterol and triglyceride levels in adults. It is prescribed for the prevention of cardiovascular complications in patients with a history of ischemic heart disease or acute coronary syndrome, as well as for adjunctive therapy in hypercholesterolemia.
Form: tablets, film-coated
Active substance Dosage rosuvastatin 5 mg ezetimibe 10 mg ATC: C10BA06
Manufacturer: Elpen Pharmaceutical Co. Inc.
-
The drug is used to lower cholesterol levels in primary hypercholesterolemia (including familial) and as an adjunct to diet. It is also prescribed for the prevention of cardiovascular complications in patients with a history of ischemic heart disease or acute coronary syndrome.
Form: tablets, film-coated
Active substance Dosage rosuvastatin 10 mg ezetimibe 10 mg ATC: C10BA06
Manufacturer: Elpen Pharmaceutical Co. Inc.
-
The drug is prescribed to adults for the treatment of elevated cholesterol levels (hypercholesterolemia) as an adjunct to diet, if the use of individual drugs (rosuvastatin or ezetimibe) has not yielded sufficient results.
Form: capsules, hard
Active substance Dosage rosuvastatin 40 mg ezetimibe 10 mg ATC: C10BA06
Manufacturer: PJSC Pharmaceutical Plant Egis (full production cycle, including batch release)
-
The drug is prescribed for adults to treat elevated cholesterol levels (hypercholesterolemia) if diet and the use of individual components (rosuvastatin or ezetimibe) do not provide adequate disease control.
Form: capsules, hard
Active substance Dosage rosuvastatin 20 mg ezetimibe 10 mg ATC: C10BA06
Manufacturer: PJSC Pharmaceutical Plant Egis (full production cycle, including batch release)
-
The drug is prescribed for adults to treat elevated cholesterol levels (hypercholesterolemia) as an adjunct to diet, if disease control is not achieved using a single component alone.
Form: capsules, hard
Active substance Dosage rosuvastatin 10 mg ezetimibe 10 mg ATC: C10BA06
Manufacturer: PJSC Pharmaceutical Plant Egis (full production cycle, including batch release)
-
The drug is intended for the treatment of adults with primary hypercholesterolemia (high cholesterol levels) as an adjunct to diet or other non-pharmacological measures.
Form: tablets, film-coated
Active substance Dosage rosuvastatin 10 mg ezetimibe 10 mg ATC: C10BA06
Manufacturer: Elpen Pharmaceuticals Co., Inc. (full production cycle; primary and secondary packaging, quality control and batch release)
-
The drug is intended for adults with high cholesterol levels (hypercholesterolemia) as an adjunct to diet and other measures (e.g., physical exercise).
Form: tablets, film-coated
Active substance Dosage rosuvastatin 20 mg ezetimibe 10 mg ATC: C10BA06
Manufacturer: Elpen Pharmaceuticals Co., Inc. (full production cycle; primary and secondary packaging, quality control and batch release)
-
The drug is prescribed for the treatment of lipid metabolism disorders (dyslipidemias), specifically to reduce cholesterol and triglyceride levels in the blood. It is used in familial hypercholesterolemia, mixed dyslipidemias, and other forms of elevated cholesterol levels, as well as for adjuvant therapy to reduce sitosterol and campesterol levels.
Form: tablets, film-coated
Active substance Dosage atorvastatin 10 mg ezetimibe 10 mg ATC: C10BA05
Manufacturer: Mepro Pharmaceuticals Private Limited